A1ln34 Stock Cash And Equivalents
| A1LN34 Stock | BRL 73.50 0.84 1.16% |
A1LN34 fundamentals help investors to digest information that contributes to A1LN34's financial success or failures. It also enables traders to predict the movement of A1LN34 Stock. The fundamental analysis module provides a way to measure A1LN34's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to A1LN34 stock.
A1LN34 |
A1LN34 Company Cash And Equivalents Analysis
A1LN34's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current A1LN34 Cash And Equivalents | 1.9 B |
Most of A1LN34's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, A1LN34 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, A1LN34 has 1.9 B in Cash And Equivalents. This is 131.46% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The cash and equivalents for all Brazil stocks is 29.68% higher than that of the company.
A1LN34 Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses A1LN34's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of A1LN34 could also be used in its relative valuation, which is a method of valuing A1LN34 by comparing valuation metrics of similar companies.A1LN34 is currently under evaluation in cash and equivalents category among its peers.
A1LN34 Fundamentals
| Return On Equity | -78.71 | |||
| Return On Asset | -13.65 | |||
| Profit Margin | (128.96) % | |||
| Operating Margin | (109.35) % | |||
| Current Valuation | 5.15 B | |||
| Shares Outstanding | 2.35 B | |||
| Price To Book | 6.22 X | |||
| Price To Sales | 170.35 X | |||
| Revenue | 687.53 M | |||
| Gross Profit | 414.8 M | |||
| EBITDA | (708.47 M) | |||
| Net Income | (886.68 M) | |||
| Cash And Equivalents | 1.9 B | |||
| Cash Per Share | 15.99 X | |||
| Total Debt | 761.07 M | |||
| Debt To Equity | 0.89 % | |||
| Current Ratio | 4.91 X | |||
| Book Value Per Share | 7.89 X | |||
| Cash Flow From Operations | (590.99 M) | |||
| Earnings Per Share | (37.45) X | |||
| Number Of Employees | 1.45 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 117.12 B | |||
| Z Score | 91.8 |
About A1LN34 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze A1LN34's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of A1LN34 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of A1LN34 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in A1LN34 Stock
A1LN34 financial ratios help investors to determine whether A1LN34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in A1LN34 with respect to the benefits of owning A1LN34 security.